DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20170817

Drug utilization study of off-label drug use in outpatient department of psychiatry: a prospective study at a tertiary care teaching hospital

Meeta D. Vadher, Kamlesh Patel, D. K. Vadher, Sujal Parkar, Chintan Raval

Abstract


Background: In the absence of standard psychiatric prescribing information, physician often use drugs in an off-label way. Many studies have been published across the globe reporting different rates of off-label use. There is currently no study based on Indian Drug Formulary.

Methods: After taking permission from Institutional Ethics Committee (IEC), a prospective study was conducted among 285 patients attending Psychiatry outpatient department for the period of 4 months. Data related to demographic parameters, diagnosis of psychiatry conditions and drugs details were collected directly from the patient's medical records and entered in Case Record Form (CRF).The off-label drugs were categorized as per National Formulary of India. Multivariate binary logistic regression model was used to determine the predictors of off- label drug prescribing. The data were statistically analyzed using SPSS version 19 and chi-square test.

Results: A total of 285 patients (169 males, 116 females) were included in the study with mean age of 36.54±13.91 years. Most of the patients (n=65, 22.8%) were diagnosed as schizophrenic. Out of 285 patients, 133(46.6%) received at least one off-label drug. A total 841 drugs were prescribed out of which 167(19.85%) were off-label. The drug most frequently prescribed as off-label were trihexiphenidyl HCL 29 (10.2%), clozapine 23 (8.1%) and clonazepam 13 (4.6%).

Conclusions: Off label drugs used among psychiatry patients was 19.85%. The most frequently used off-label drugs was trihexiphenidyl HCL. The use of off-label drugs in psychiatric patients has been reportedly increasing which warrant national drug regulatory authorities to review and revise safe administration such drugs.


Keywords


Label drug, Psychiatry, Prescription, Outpatients, Off-label drug

Full Text:

PDF

References


Regulating Off-Label Drug Use- Rethinking the Role of the FDA, 2008. N Engl J Med. Available at http://www.nejm.org/doi/full/10.1056/NEJMp0802107. Accessed 23 Oct 2016.

Edersheim JG. Off-label Prescribing. Prescribing Times, 2009. Available at http://www.psychiatrictimes.com/articles/labelprescribing#sthash.a9MTKKtC.dpuf. Accessed 11 September 2016.

Stafford RS. Regulating off-label drug use- Rethinking the role of the FDA. N Engl J Med. 2008;358(14):1427-29.

Bavdekar SB, Gogtay NJ. Unlicensed and off-label drug use in children. J Postgrad Med. 2005;51(4):249-52.

Baldwin D, Kosky N. Off-label prescribing in psychiatric practice. Adv Psychiatr Treat. 2007;13:414-22.

Wittich CM, Burkle CM, Lanier WL. Ten common questions (and their answers) about off-label drug use. Mayo Clin Proc. 2012;87(10):982-90.

Wong I, Murray M, Camilleri-Novak, D. Stephens P. Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child. 2004;89:1131-32.

Douglas-Hall P, Fuller A, Gill-Banham S. An analysis of off-licence prescribing in psychiatric medicine. Pharm J. 2001;267:890-1.

Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166(9):1021-6.

Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. Br J Psychiatry. 2012;200:393-98.

Kharadi D, Patel K, Rana D, Patel V. Off-label drug use in psychiatry outpatient department: A prospective study at a tertiary care teaching hospital. J Basic Clin Pharma. 2015;6(2):45-9.

Jacob MK, Ammu A, Annie Eapen B, Behnan A, Prabha S. Evaluation of off Label Drug Use in the Outpatient Department of a Psychiatry Hospital. Int. J Pharm. Sci Rev Res. 2016;40(1):206-10.

Indian Pharmacopeia Commission, National Formulary of India, 5th editon, India. 2016.

Thakkar K, Jain M, Billa G, Joshi A, Khobragade A. A drug utilization study of psychotropic drugs prescribed in the Psychiatry Outpatient Department of a Tertiary Care Hospital. J Clin Diagn Res. 2013;7:2759-64.

Piparva K, Parmar D, Singh A, Gajera M, Trivedi H. Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital. Ind J Psychol Med. 2011;33:54-8.

Sarang A, Shaikh TE. Evaluation of psychotropic drugs use pattern among out patients attending psychiatry department at government medical college and hospital, nagpur: a cross sectional study. Int J Pharm Bio Sci. 2012;3(3):428-36.

Burgyone K, Aduri K, Ananth J, Parameswaran S. The use of antiparkinsonian agents in the management of drug induced extrapyramidal symptoms, Curr Pharmaceutical Design. 2004;10(18):2239-48.

Paton C, Banham S, Whitmore J. Benzodiazepines in schizophrenia. Is there a trend towards long-term prescribing? B J Psych Bulletin. 2000;24:113-15.

Bose D, Muraraiah S, Chandrashekar H. Evaluation of patterns and predictors of offlabel prescribing of antidepressants in psychiatry at a tertiary care hospital - An analytical cross-sectional study. Natl J Physiol Pharm Pharmacol. 2017;7:1-6.

Curtin F, Schulz P. Clonazepam and lorazepam in acute mania: a Bayesian meta analysis, Journal of Affective Disorders. 2004;78:201-08.

Dold M, Li C, Gillies D, Leucht S. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and Cochrane review of randomized controlled trials. Eur Neuro Psychopharmacol. 2013;23:1023-33.

Taylor D, Starkey K, Ginary S. Prescribing and monitoring of carbamazepine and valproate- a case note review. Psychiatr Bull. 2000;24:174-77.

Bradford D, Perkins D, Lieberman J. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses. Drugs. 2003;63:2265-83.

Sugarman P, Mitchell A, Frogley C, Dickens G, Picchioni M. Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance Ther Adv Psychopharmacol. 2013;3(4):233-43.

Grunze H. The effectiveness of anticonvulsants in psychiatric disorders, Dialogues in Clinical Neuroscience. 2008;10(1):77-89.

Fountoulakis K, Nimatoudis I, Iacovides A, Kaprinis G. Off-label indications for atypical antipsychotics: A systematic review .Annals of General Hospital Psychiatry. 2004;3:1-10.

Pickar D, Jessie V, John J. Bartko Pharmacotherapy of Schizophrenic Patients: Preponderance of Off-Label Drug Use. 2008;3(9):3150.

Guay D. Adjunctive agents in the management of chronic pain. Pharmacotherapy. 2001;21(9):1070-81.

Joint Formulary Committee, British National Formulary. 61st ed. London: Pharmaceutical Press, Royal Pharmaceutical Society; 2011.